Regeneron Pharmaceuticals Inc. v. Biogen Inc.

Regeneron Pharmaceuticals Inc. has filed an application with the United States District Court for the District of Delaware seeking permission to obtain discovery from Biogen Inc. “for use in foreign patent-infringement litigation and related proceedings brought by Regeneron against Samsung Bioepis Co., Ltd., and Samsung Biologics Co., Ltd., currently pending in South Korea.”